A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group Study (GOG 146Q)
- Thomas J. Herzog
- , Michael W. Sill
- , Joan L. Walker
- , David O'Malley
- , Mark Shahin
- , Koen Degeest
- , Sheldon A. Weiner
- , David Mutch
- , Robert L. Debernardo
- , Samuel S. Lentz
Research output: Contribution to journal › Article › peer-review
26
Link opens in a new tab
Scopus
citations